Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer

Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer

Statins are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGR) inhibitors decreasing serum cholesterol and have shown promise in cancer prevention. In this study, we demonstrated the oncogenic role of HMGR in colorectal cancer (CRC) by disclosing increased HMGR activity in CRC patients...

Full description

Bibliographic Details
Main Authors:	Tzu-Tang Wei, Yi-Ting Lin, Wen-Shu Chen, Ping Luo, Yu-Chin Lin, Chia-Tung Shun, Yi-Hsin Lin, Jhih-Bin Chen, Nai-Wei Chen, Jim-Min Fang, Ming-Shiang Wu, Kai-Chien Yang, Li-Chun Chang, Kang-Yu Tai, Jin-Tung Liang, Ching-Chow Chen
Format:	Article
Language:	English
Published:	Elsevier 2016-08-01
Series:	EBioMedicine
Subjects:	Colorectal cancer HMG-CoA reductase Histone deacetylase Statin hydroxamate Preclinical model
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396416303243

Similar Items

Association of Common and Rare Genetic Variation in the 3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Gene and Cataract Risk
by: Jonas Ghouse, et al.
Published: (2022-06-01)

3-Hydroxy-3-methylglutaryl coenzyme A reductase in isolated villous and crypt cells of the rat ileum
by: J L Merchant, et al.
Published: (1977-11-01)

Isolation and purification of 3-hydroxy-3-methylglutaryl-coenzyme A by ion-exchange chromatography
by: I P Williamson, et al.
Published: (1981-01-01)

The quantitative assay of 3-hydroxy-3-methylglutaryl coenzyme A reductase: comparison of a thin-layer chromatographic assay with a rapid chloroform extraction assay
by: M E Ackerman, et al.
Published: (1977-05-01)

Antihyperlipidemic Activity of Hydroxyl Methylglutaryl Coenzyme A Reductase Inhibitor on Lipid Profile in Secondary Hyperlipidemia
by: Naveed Ali Siddiqui, et al.
Published: (2020-09-01)

7-Acetoxyhorminone from <i>Salvia multicaulis</i> Vahl. as Promising Inhibitor of 3-Hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase
by: Serkan Yigitkan, et al.
Published: (2022-02-01)

Effects of atrovastatin on concentrations of 3-hydroxy-3-methylglutaryl-coenzyme A- reductase (HMG-CoA-R), proprotein convertase subtilisin/kexin type 9 (PCSK9) and sortilin in patients with type 2 diabetes mellitus and pre-diabetics
by: Ali Nosrati Andevari, et al.
Published: (2021-01-01)

Are statins toxic or safe for kidney diseases? An updated mini-review study
by: Shadi Botshekan, et al.
Published: (2020-10-01)

Estatinas hipolipêmicas e novas tendências terapêuticas Hypolipemic statins and new therapeutcal trends
by: Vanessa Leiria Campo, et al.
Published: (2007-04-01)

Inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase enzyme by dipeptides identified in dry-cured ham
by: Alejandro Heres, et al.
Published: (2021-07-01)

A Case of Immune-Mediated Necrotizing Myopathy in a 75-Year-Old with Anti-HMG-CoA Reductase Antibodies
by: Dylan Smith, et al.
Published: (2023-01-01)

Beneficial Effects of Statins on Seizures Independent of Their Lipid-Lowering Effect: A Narrative Review
by: Arash Amanlou, et al.
Published: (2023-01-01)

Laboratory tests and clinical significance of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibody
by: Jing-jing LUO, et al.
Published: (2016-09-01)

Statins—From Fungi to Pharmacy
by: Anna Sadowska, et al.
Published: (2023-12-01)

Statins in clinical medicine
by: Swiss Medical Weekly
Published: (2011-11-01)

Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia
by: Yu-An Chen, et al.
Published: (2018-03-01)

Thiết kế, tổng hợp và đánh giá khả năng ức chế enzyme histone deacetylase (HDAC) in silico của một số dẫn xuất tương tự belinostat
by: Nguyễn Cường Quốc, et al.
Published: (2020-06-01)

Design, synthesis and biological evaluation of novel histone deacetylase inhibitors based on virtual screening
by: Hui Lu, et al.
Published: (2011-12-01)

A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with <i>HMGCR</i> Genetic Variation in Parkinson’s Disease
by: Anna Pierzchlińska, et al.
Published: (2021-11-01)

Lepidopteran HMG-CoA reductase is a potential selective target for pest control
by: Yuan-mei Li, et al.
Published: (2017-01-01)

Potential drug interactions with statins: Estonian register-based study
by: Gavronski Maia, et al.
Published: (2015-04-01)

Targeting the Tumor Microenvironment: A Literature Review of the Novel Anti-Tumor Mechanism of Statins
by: Peng-Fei Zhu, et al.
Published: (2021-11-01)

A Japanese case of mitochondrial 3‐hydroxy‐3‐methylglutaryl‐CoA synthase deficiency who presented with severe metabolic acidosis and fatty liver without hypoglycemia
by: Tomoko Lee, et al.
Published: (2019-07-01)

Association between Genetically Proxied Inhibition of HMG-CoA Reductase and Age at Onset of Huntington’s Disease
by: Yahui Zhu, et al.
Published: (2022-11-01)

Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases
by: Anton Frühauf, et al.
Published: (2021-08-01)

A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma
by: Hao Wang, et al.
Published: (2021-11-01)

Hesperidin Interaction with HMG-CoA-Reductase Enzyme in Hypercholesterolemia: A Study in Silico
by: Annisa Rizqi Dwi Oktaviani, et al.
Published: (2021-09-01)

The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
by: Huanbiao Mo, et al.
Published: (2019-01-01)

Case report: Diagnostic clues for anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy in pediatric patients
by: Keisuke Watanuki, et al.
Published: (2023-03-01)

Statin Use Is Associated With a Lower Risk of Blepharitis: A Population-Based Study
by: Kathy Ming Feng, et al.
Published: (2022-03-01)

The Impact of Statin Use and Breast Cancer Recurrence - A Retrospective Study in Singapore
by: Yirong Sim, et al.
Published: (2022-03-01)

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
by: Marinella Zilli, et al.
Published: (2013-07-01)

Statin Supply and Polydrug Use in Older Adults: A Focus on Drug Combinations that Reduce Bone Density
by: JaHyun Ho, et al.
Published: (2021-12-01)

An ultrasensitive enzymatic method for measuring mevalonic acid in serum
by: Takeshi Matsuoka, et al.
Published: (2012-09-01)

An Atypical Case of Head Tremor and Extensive White Matter in an Adult Female Caused by 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency
by: Nassim Boutouchent, et al.
Published: (2021-08-01)

Dissection of Anti-tumor Activity of Histone Deacetylase Inhibitor SAHA in Nasopharyngeal Carcinoma Cells via Quantitative Phosphoproteomics
by: Huichao Huang, et al.
Published: (2020-11-01)

Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A
by: Frank H. Hulcher, et al.
Published: (1973-11-01)

Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis
by: Myriam Jaam, et al.
Published: (2023-02-01)

Cloning and Characterization of the Gene Encoding 3-hydroxy-3- Methylglutaryl-coenzyme A (HMG-CoA) Reductase from Fritillaria Cirrhosa D. Don
by: Qi Zhao, et al.
Published: (2018-11-01)

Influence of simvA glyzin on expression and inhibition of hmg-coa reductase in rats liver
by: Yu. I. Ragino, et al.
Published: (2015-06-01)